Retinoic acid

Produktnummer ABIN1027857

Produktdetails

Verwendungszweck: Retinoid RAR agonist

Produktmerkmale: Retinoid RAR agonist.

Reinheit: >98 %

Chemical Name: Tretinoin, ATRA

Formel: C20H28O2

Löslichkeit: Soluble to 50 mM in ethanol and 25 mM in DMSO

Anwendungsinformationen

Kommentare:

Source: Synthetic.
Appearance: Yellow solid

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Solid

Vorsichtsmaßnahmen: Classification: Toxic. May be harmful or fatal is inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R20/21/22 - Harmful by inhilation, in contact with skin and if swallowed R40 - Limited evidence of a carcinogenic effect R46 - May cause heritable genetic damage R62 - Possible risk of impaired fertility Hazard Phrases: H302-H411 Precautionary Phrases: P273

Handhabung: Classification: Toxic. May be harmful or fatal is inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R20/21/22 - Harmful by inhilation, in contact with skin and if swallowed R40 - Limited evidence of a carcinogenic effect R46 - May cause heritable genetic damage R62 - Possible risk of impaired fertility Hazard Phrases: H302-H411 Precautionary Phrases: P273

Lagerung: -20 °C

Antigendetails

Hintergrund: Retinoic acid is a metabolite of Vitamin A that mediates the functions of vitamin A required for growth and development. It is generated in a specific region of the embryo during early embryonic development.
Synonyms: Tretinoin, ATRA

Molekulargewicht: 300.44

CAS-Nummer: 302-79-4